Trial intelligence / Profile preview

Olanzapine vs Ziprasidone Metabolic Effects in Healthy Volunteers

NCT00297960Phase 4Completed

Sponsor
Medical University of Vienna
Start
Apr 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine, ziprasidone in schizophrenia, sponsored by Medical University of Vienna. Started Apr 2005; status: completed.

02

Drugs

olanzapineziprasidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00297960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00297960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call